Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report
This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.
Authors
- Yanrong Ji (ORCID: https://orcid.org/0000-0002-0134-664X)
- Yingyi Fan (ORCID: https://orcid.org/0009-0009-4571-7340)
- Yingying Wang (ORCID: https://orcid.org/0000-0002-2218-3237)
- Jian Zhang (ORCID: https://orcid.org/0009-0009-4221-7113)
- Shuang Li (ORCID: https://orcid.org/0000-0002-0550-8722)
- Xingliang Hao
Institutions
- Shengli Oilfield Central Hospital (CN)
Publication Details
- Journal
- The Clinical Respiratory Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/crj.70009
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical and Health Science and Technology Development Project of Shandong Province